Physicochemical and Pharmacokinetic Profiles of Gadopiclenol A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity (Aug 2019).

Written By Bridget Belo

Journal: Investigative Radiology

Article Links: https://journals.lww.com/investigativeradiology/fulltext/2019/08000/physicochemical_and_pharmacokinetic_profiles_of.5.aspx

Authors and Affiliations: Robic, Caroline PhD*; Port, Marc PhD†; Rousseaux, Olivier PhD*; Louguet, Stéphanie PhD*; Fretellier, Nathalie PhD*; Catoen, Sarah PhD*; Factor, Cécile PhD*; Le Greneur, Soizic PhD*; Medina, Christelle PhD*; Bourrinet, Philippe PharmD*; Raynal, Isabelle PhD*; Idée, Jean-Marc PharmD, MS*; Corot, Claire PharmD, PhD

From the *Research and Innovation Division, Guerbet, Aulnay-sous-Bois; and

†Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Equipe Chimie Moléculaire, Conservatoire National des Arts et Métiers (CNAM), HESAM Université, Paris, France.

Received for publication January 21, 2019; and accepted for publication, after revision, February 21, 2019.

Conflicts of interest and sources of funding: All authors are or were employees of Guerbet. This work is part of the Franco-German Project ISEULT and was funded in part by Banque Publique d’Investissement (France) and by Guerbet.

Correspondence to: Jean-Marc Idée, PharmD, MS, Research and Innovation Division, Guerbet, BP 57400 Roissy-Charles de Gaulle Cedex, France. E-mail: jean-marc.idee@guerbet.com.

Bridget Belo
Previous

Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation (Jan 2020).
Next

Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent (2019).